SIMONE BLANK - 07 Feb 2024 Form 4 Insider Report for Evolus, Inc. (EOLS)

Role
Director
Signature
/s/ Jeffrey J. Plumer, as attorney-in-fact for Simone Blank
Issuer symbol
EOLS
Transactions as of
07 Feb 2024
Net transactions value
$0
Form type
4
Filing time
09 Feb 2024, 18:38:08 UTC
Previous filing
15 Aug 2023
Next filing
11 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EOLS Common Stock Award $0 +6,464 +10% $0.000000 69,747 07 Feb 2024 Direct F1
holding EOLS Common Stock 482,783 07 Feb 2024 See Footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EOLS Stock Option (Right to Buy) Award $0 +9,377 $0.000000 9,377 07 Feb 2024 Common Stock 9,377 $13.15 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of February 7, 2024, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer.
F2 Represents shares held by Dental Innovations Apus Investment BV ("DIAI") and may be deemed beneficially owned by the Reporting Person as the sole beneficial owner of DIAI.
F3 The shares subject to the option will vest over a period of twelve months, with 1/12th of the shares subject to the option vesting monthly on the anniversary of February 7, 2024, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.